An HIV-1 replication pathway utilizing reverse transcription products that fail to integrate.
about
Contribution of HIV-1 genomes that do not integrate to the basic reproductive ratio of the virus.Persistent production of an integrase-deleted HIV-1 variant with no resistance mutation and wild-type proviral DNA in a treated patientIntegrase inhibitor reversal dynamics indicate unintegrated HIV-1 dna initiate de novo integration.Suppression of Foxo1 activity and down-modulation of CD62L (L-selectin) in HIV-1 infected resting CD4 T cells.Understanding Factors That Modulate the Establishment of HIV Latency in Resting CD4+ T-Cells In Vitro.HIV-1 latency and virus production from unintegrated genomes following direct infection of resting CD4 T cells.Germinal Center T Follicular Helper Cells Are Highly Permissive to HIV-1 and Alter Their Phenotype during Virus ReplicationA Subset of CD4/CD8 Double-Negative T Cells Expresses HIV Proteins in Patients on Antiretroviral Therapy.HIV-1 Vpr-a still "enigmatic multitasker".Different Pathways Leading to Integrase Inhibitors ResistanceEstablishment and Reversal of HIV-1 Latency in Naive and Central Memory CD4+ T Cells In Vitro.LEDGF/p75 Deficiency Increases Deletions at the HIV-1 cDNA Ends.Potent Inhibition of HIV-1 Replication in Resting CD4 T Cells by Resveratrol and Pterostilbene.Protein expression from unintegrated HIV-1 DNA introduces bias in primary in vitro post-integration latency modelsHIV-1 Vpr- and Reverse Transcription-Induced Apoptosis in Resting Peripheral Blood CD4 T Cells and Protection by Common Gamma-Chain Cytokines.On the laws of virus spread through cell populations.Insight into HIV-2 latency may disclose strategies for a cure for HIV-1 infection.Proviruses with Long-Term Stable Expression Accumulate in Transcriptionally Active Chromatin Close to the Gene Regulatory Elements: Comparison of ASLV-, HIV- and MLV-Derived Vectors.Tat controls transcriptional persistence of unintegrated HIV genome in primary human macrophages.
P2860
Q27309008-F1111A08-A8AE-4FBA-BE02-5F16117BE53EQ34871994-FACC3386-1645-4582-A7F5-AB7A2C949FBAQ35213243-758CF88F-CFE3-47BC-A2C6-263F53CD9A6BQ35350405-9781452A-BF52-420B-BEB7-50428B39CC38Q36068841-B74D2BDD-8C67-4CA2-9935-57B8C7DC2236Q36428308-CCC5DC2C-A4F8-4DD1-9027-69809A8923A2Q36655850-906973EB-CD00-4971-8813-F2032899B688Q36736780-5E0A6B99-068C-4C37-AE78-C05319C6D4D6Q37689513-A42FBCFB-EDF4-42B9-91E3-B56846C4C5D1Q39103603-017538CF-A5B9-41F2-87A5-4C8257748F35Q39645005-DC50DDEB-438D-4029-8A69-0C45BCA36F98Q40038972-CE24A2B1-E42E-4F35-AADC-F79C44B580AFQ40144743-11FA6CE9-DA7C-4599-AD35-96EC50CFBFCCQ40426527-A152FCE7-FA92-4493-8874-DC652D35D9FDQ40922628-BDE46A02-75C0-4633-B597-66F5BAD4536EQ41754641-AE98FE80-F61E-40D6-A579-44EBBE3388D6Q42318282-308826D6-9F1C-4DCD-89F5-6753A6DECBE3Q52362927-F83738DE-6EA0-4FCC-A4F3-F458C6721580Q54254325-918EE5F7-AFEE-46AA-8473-4E4520B043E0
P2860
An HIV-1 replication pathway utilizing reverse transcription products that fail to integrate.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
An HIV-1 replication pathway u ...... oducts that fail to integrate.
@en
An HIV-1 replication pathway u ...... oducts that fail to integrate.
@nl
type
label
An HIV-1 replication pathway u ...... oducts that fail to integrate.
@en
An HIV-1 replication pathway u ...... oducts that fail to integrate.
@nl
prefLabel
An HIV-1 replication pathway u ...... oducts that fail to integrate.
@en
An HIV-1 replication pathway u ...... oducts that fail to integrate.
@nl
P2093
P2860
P356
P1433
P1476
An HIV-1 replication pathway u ...... oducts that fail to integrate.
@en
P2093
Benjamin Trinité
Chi N Chan
David N Levy
Dominik Wodarz
Eric C Ohlson
Igor Voznesensky
Jason Alster
Saurabh Mahajan
Sean A Burke
Shashank P Rana
P2860
P304
12701-12720
P356
10.1128/JVI.01939-13
P407
P577
2013-09-18T00:00:00Z